PharMatheve: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PharMatheve
Largest movements
- Cash +€28,775
up €28,775 (+78.6%), from €36,620 to €65,395
mainly Net result for the year (+€48,137) and Trade debts (+€2,204)
- Receivables within one year +€20,364
up €20,364 (+316.0%), from €6,444 to €26,808
of which Trade receivables: +€11,148
- Deferred charges and accrued income +€1,768
up €1,768 (+10430.3%), from €17 to €1,785
- Reserves +€48,137
up €48,137 (+107.9%), from €44,632 to €92,769
- Trade debts +€2,204
up €2,204 (+386.9%), from €570 to €2,774
- Gross operating margin +€2,860
up €2,860 (+4.8%), from €59,991 to €62,851
- Depreciation +€1,619
up €1,619 (+444.8%), from €364 to €1,984
- Taxes +€909
up €909 (+7.6%), from €11,889 to €12,798
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €48,668 | €98,938 | +€50,270 | +103.3% |
| Fixed assets | 21/28 | €5,587 | €4,950 | -€636 | -11.4% |
| Tangible fixed assets | 22/27 | €5,587 | €4,950 | -€636 | -11.4% |
| Furniture and vehicles | 24 | €5,587 | €4,950 | -€636 | -11.4% |
| Current assets | 29/58 | €43,081 | €93,987 | +€50,907 | +118.2% |
| Amounts receivable within one year | 40/41 | €6,444 | €26,808 | +€20,364 | +316.0% |
| Trade receivables | 40 | €952 | €12,100 | +€11,148 | +1170.8% |
| Other amounts receivable | 41 | €5,491 | €14,708 | +€9,216 | +167.8% |
| Cash at bank and in hand | 54/58 | €36,620 | €65,395 | +€28,775 | +78.6% |
| Deferred charges and accrued income | 490/1 | €17 | €1,785 | +€1,768 | +10430.3% |
| Total equity and liabilities | 10/49 | €48,668 | €98,938 | +€50,270 | +103.3% |
| Equity | 10/15 | €45,632 | €93,769 | +€48,137 | +105.5% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €44,632 | €92,769 | +€48,137 | +107.9% |
| Distributable reserves | 133 | €44,632 | €92,769 | +€48,137 | +107.9% |
| Amounts payable | 17/49 | €3,035 | €5,169 | +€2,134 | +70.3% |
| Amounts payable within one year | 42/48 | €3,035 | €5,169 | +€2,134 | +70.3% |
| Trade debts | 44 | €570 | €2,774 | +€2,204 | +386.9% |
| Suppliers | 440/4 | €570 | €2,774 | +€2,204 | +386.9% |
| Taxes, remuneration and social security | 45 | €1,633 | €2,395 | +€763 | +46.7% |
| Taxes | 450/3 | €1,633 | €2,395 | +€763 | +46.7% |
| Other amounts payable | 47/48 | €833 | - | -€833 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €364 | €1,984 | +€1,619 | +444.8% |
| Other operating charges | 640/8 | €236 | €240 | +€4 | +1.7% |
| Gross operating margin | 9900 | €59,991 | €62,851 | +€2,860 | +4.8% |
| Operating profit (loss) | 9901 | €59,391 | €60,627 | +€1,236 | +2.1% |
| Financial income | 75/76B | €91 | €425 | +€334 | +368.0% |
| Recurring financial income | 75 | €91 | €425 | +€334 | +368.0% |
| Financial charges | 65/66B | €143 | €117 | -€25 | -17.8% |
| Recurring financial charges | 65 | €143 | €117 | -€25 | -17.8% |
| Profit (loss) for the period before taxes | 9903 | €59,339 | €60,935 | +€1,596 | +2.7% |
| Income taxes | 67/77 | €11,889 | €12,798 | +€909 | +7.6% |
| Profit (loss) for the period | 9904 | €47,450 | €48,137 | +€687 | +1.4% |
| Profit (loss) for the period to be appropriated | 9905 | €47,450 | €48,137 | +€687 | +1.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.